Partnership Applications Now Open Washington, DC – March 7, 2022 – Global Liver Institute (GLI) will convene the fifth International NASH Day (#NASHday) on June 9, 2022 with the theme Stop NASH...
Global Liver Institute
GLI’s Liver Action Network Supports World Obesity Day to Acknowledge Strong Connection Between NASH and Obesity
GLI’s Liver Action Network Supports World Obesity Day to Acknowledge Strong Connection Between NASH and Obesity As members of Global Liver Institute’s Liver Action Network (LAN), the undersigned...
Liver Action Network Announces New Partnership with Empire Liver Foundation
(Washington, D.C., March 2, 2022) – Global Liver Institute (GLI) proudly announces the expansion of the Liver Action Network (LAN) to include a partnership with Empire Liver...
Global Liver Institute Applauds the Confirmation of New Food and Drug Administration Commissioner Dr. Robert Califf
(Washington, DC, Wednesday, February 16, 2022)—Today, Global Liver Institute (GLI) applauds the confirmation of the new Food and Drug Administration (FDA) Commissioner Dr. Robert Califf. On Tuesday,...
Global Liver Institute Leads Second Annual Rare Liver Diseases Month
Transforming the Public Consciousness with Conversations for and about the Rare Liver Disease Community WASHINGTON, DC, FEBRUARY 1, 2022 – Global Liver Institute (GLI), a patient-led...
January Liver Health Policy Update
POLICY PERSPECTIVE Rapid advancements to policy and committees welcomed in the new year. One of the most highlighted actions was the advancement of the nomination of Dr. Robert Califf as the...
New Year, Fresh Perspectives
Fatty liver disease (FLD) and nonalcoholic steatohepatitis (NASH) are increasing in prevalence worldwide, creating a major global public health crisis. To adequately educate patients, practitioners,...
Good News, New Tools! Combatting COVID-19 in 2022
As we enter a third calendar year marked by COVID-19, the Omicron variant has caused pandemic peaks in cases and hospitalizations. However, we also have a greater understanding of the disease–and...
Global Liver Institute Announces New Leadership of GLI’s Liver Action Network
Washington, DC, January 14, 2022 – In 2021, the Global Liver Institute (GLI) formed the Liver Action Network (LAN) to better synchronize engagement across the liver advocacy...
Global Liver Institute and TriSalus Life Sciences Partner To Launch “Liver Central,” a New Resource Hub for Liver Cancer Researchers, Clinicians and Patients
WASHINGTON, DC and DENVER, JANUARY 6, 2021 – The Global Liver Institute (GLI), the only patient-led liver health nonprofit operating internationally, in partnership with TriSalus Life...
Recent News